About SGRL
SGRL is a company based in Ankleshwar (India) founded in 1995 by Chanudubhai Manubhai Kothia. The company has 149 employees as of March 31, 2024. SGRL offers products and services including Bis(2-chloroethyl)amine hydrochloride, 4-Chloro-4-fluorobutyrophenone, Diphenylacetonitrile, Trityl chloride, and 2-Furoyl chloride. SGRL operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Ankleshwar, India
- Employees 149 as on 31 Mar, 2024
- Founders Chanudubhai Manubhai Kothia
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Shree Ganesh Remedies Ltd.
-
Annual Revenue
$12.76 M (USD)-13.74as on Mar 31, 2025
-
Net Profit
$2.7 M (USD)-17.93as on Mar 31, 2025
-
EBITDA
$4.72 M (USD)-5.83as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
149
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SGRL
SGRL is a publicly listed company on the BSE with ticker symbol SGRL in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of SGRL
SGRL offers a comprehensive portfolio of products and services, including Bis(2-chloroethyl)amine hydrochloride, 4-Chloro-4-fluorobutyrophenone, Diphenylacetonitrile, Trityl chloride, and 2-Furoyl chloride.
Intermediate for pharmaceutical synthesis and reactions.
Used in drug manufacturing processes.
Component for API intermediates.
Essential for organic synthesis in pharmaceuticals.
Applied in fine chemical production.
Funding Insights of SGRL
Detailed funding history for SGRL
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SGRL
Investment portfolio details for SGRL
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SGRL
Detailed financials for SGRL
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sgrl Comparisons
Peer comparison for SGRL
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SGRL
SGRL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of SGRL
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sgrl
Complete news archive for SGRL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SGRL
SGRL was founded in 1995.
SGRL is headquartered in Ankleshwar, India. It is registered at Ankleshwar, Gujarat, India.
Chanudubhai Manubhai Kothia is the current CEO of SGRL. They have also founded this company.
As of Mar 31, 2024, the latest employee count at SGRL is 149.
Annual revenue of SGRL is $12.76M as on Mar 31, 2025.
Manufacturer of pharmaceutical drug intermediates for API and fine chemical industry. It is a healthcare company offering manufacturing of pharmaceutical intermediates and fine chemicals including anti depressant, diabetic, cancer, fungal arrhythmic and more API intermediates.
SGRL's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
SGRL offers Bis(2-chloroethyl)amine hydrochloride, 4-Chloro-4-fluorobutyrophenone, Diphenylacetonitrile, Trityl chloride, and 2-Furoyl chloride.
Yes, SGRL is publicly traded on BSE under the ticker symbol SGRL.
The ticker symbol of SGRL is SGRL on BSE.